AGA Rejects ABIM’s Proposed MOC Pathways

ABIM proposes to replace the 10-year exam with either a two or five year alternative MOC Pathway.

AGA Celebrates Its Peer Reviewers

Sept. 23: Deadline for 3 AGA Recognition Prizes

Did You Answer Correctly?

AGA Rejects ABIM’s Proposed MOC Pathways

AGA Celebrates Its Peer Reviewers

Sept. 23: Deadline for 3 AGA Recognition Prizes

Did You Answer Correctly?

News

Filter
  • All
  • Celiac Disease
  • Colorectal Cancer
  • Endoscopy
  • GERD
  • Hepatitis C
  • IBD
  • Advocacy
  • Cancer prevention and treatment
  • GI practice & quality
  • Gut Microbiome & FMT
  • Hepatology
  • Lower GI disorders & procedures
  • Obesity & nutrition
  • Pancreaticobiliary disorders & procedures
  • Pediatric Gastroenterology
  • Procedures
  • Regulatory Peptides, Cell Signaling & Molecular Biology
  • Upper GI disorders & procedures

Gastroenterology

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

Sept. 27, 2016

Using MRC analysis of patients with long-term IBD, we found the prevalence of PSC to be around 3-fold higher than that detected based on symptoms.

Gastroenterology

Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families

Sept. 27, 2016

We studied 2 large Ashkenazi Jewish families with a high prevalence of CD in an attempt to identify novel genetic risk variants.

Gastroenterology

Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen

Sept. 27, 2016

We assessed the presence of hepatitis C virus RNA in liver explants from 39 patients awaiting liver transplantation who were treated with an interferon-free regimen and had undetectable serum HCV RNA at the time of liver transplantation.

Gastroenterology

Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity

Sept. 27, 2016

We investigated gluten metabolism by opportunistic pathogens and commensal duodenal bacteria and characterized the capacity of the produced peptides to activate gluten-specific T-cells from CD patients.

Gastroenterology

High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis

Sept. 27, 2016

In cirrhotic HCV GT1- or GT3-infected patients, ABT-493 plus ABT-530 with or without RBV achieved SVR12 rates of 96%–100% and was well tolerated.

Gastroenterology

ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer

Sept. 27, 2016

Emerging evidence suggests a role for RNA editing and ADARs in cancer, however, the relationship between RNA editing and GC development and progression remains unknown.

News

What's the Cause of This Patient's Gastrointestinal Ulcers?

Sept. 22, 2016

The patient was treated 15 years ago with interferon alpha for infection with HCV genotype 1, but the treatment failed to eradicate the virus.
Advertisement

News

AGA Celebrates Its Peer Reviewers

Sept. 22, 2016

AGA recognizes the important role peer reviewers play in advancing our scholarly publications. Here are a few ways we are highlighting them during Peer Review Week.